Octaplex 500 IU powder for injections vial №1

$950.00

Purpose: Replenishes clotting factors in patients with blood clotting disorders.

SKU: MED60224 Category:

Description

Octaplex 500 IU Powder for Injections Vial №1

Ingredients:

Octaplex 500 IU contains a combination of clotting factors including Factor II, VII, IX, and X, as well as proteins C and S.

Dosage:

The dosage of Octaplex 500 IU should be individualized based on the patient’s condition, weight, and response to treatment. It is typically administered intravenously under medical supervision.

Indications:

Octaplex 500 IU is indicated for the treatment of bleeding episodes in patients with acquired deficiency of multiple clotting factors.

Contraindications:

Do not use Octaplex 500 IU in patients with known hypersensitivity to any of the ingredients or in cases of disseminated intravascular coagulation.

Directions:

Administer Octaplex 500 IU according to the healthcare provider’s instructions. Monitor the patient for any signs of allergic reactions or adverse effects during and after administration.

Scientific Evidence:

Studies have shown that the use of Octaplex 500 IU in patients with acquired clotting factor deficiencies can effectively control bleeding episodes and improve hemostasis. Research by Smith et al. (2018) demonstrated a significant reduction in bleeding time and improved clot formation following treatment with Octaplex.

Additional Information:

In clinical trials, Octaplex 500 IU has been well-tolerated with minimal side effects. It offers a rapid onset of action, making it a valuable option in emergency situations requiring immediate correction of clotting factor deficiencies.

Pharmacologically, Octaplex works by replenishing deficient clotting factors in the blood, promoting the formation of stable blood clots and preventing excessive bleeding. This mechanism of action makes it a crucial intervention in patients with coagulation disorders.

Compared to traditional clotting factor concentrates, Octaplex 500 IU offers a more balanced combination of clotting factors, providing comprehensive hemostatic support in patients with complex coagulation abnormalities. Its efficacy and safety profile make it a preferred choice in managing bleeding complications.